1,760.00
+26.00
+(1.50%)
As of January 16 at 5:24:06 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
56,635.00
50,315.00
35,630.00
21,839.00
4,291.00
Cost of Revenue
13,766.00
12,834.00
9,298.00
5,603.00
1,665.00
Gross Profit
42,869.00
37,481.00
26,332.00
16,236.00
2,626.00
Operating Expense
46,517.00
45,471.00
43,670.00
25,103.00
9,177.00
Operating Income
-3,648.00
-7,990.00
-17,338.00
-8,867.00
-6,551.00
Net Non Operating Interest Income Expense
-321.00
-287.00
-804.00
-536.00
-326.00
Pretax Income
-3,954.00
-8,262.00
-19,207.00
-7,147.00
-11,687.00
Tax Provision
264.00
16.00
321.00
-321.00
--
Net Income Common Stockholders
-4,218.00
-8,278.00
-19,528.00
-6,826.00
-11,687.00
Diluted NI Available to Com Stockholders
-4,218.00
-8,278.00
-19,528.00
-6,826.00
-11,687.00
Basic EPS
-0.12
-0.24
-0.57
-0.29
-0.34
Diluted EPS
-0.12
-0.24
-0.57
-0.29
-0.34
Basic Average Shares
34,255.05
34,157.94
34,070.99
23,499.64
34,294.10
Diluted Average Shares
34,255.05
34,157.94
34,070.99
23,499.64
34,294.10
Total Operating Income as Reported
-3,648.00
-7,990.00
-17,338.00
-8,867.00
-6,551.00
Total Expenses
60,283.00
58,305.00
52,968.00
30,706.00
10,842.00
Net Income from Continuing & Discontinued Operation
-4,218.00
-8,278.00
-19,528.00
-6,826.00
-11,687.00
Normalized Income
-4,218.00
-8,278.00
-19,528.00
-6,826.00
-6,983.00
Interest Income
904.00
777.00
330.00
31.00
14.00
Interest Expense
305.00
144.00
542.00
355.00
301.00
Net Interest Income
-321.00
-287.00
-804.00
-536.00
-326.00
EBIT
-3,649.00
-8,118.00
-18,665.00
-6,792.00
-11,386.00
EBITDA
-2,001.00
-6,613.00
-17,546.00
-6,433.00
-11,321.00
Reconciled Cost of Revenue
13,766.00
12,834.00
9,298.00
5,603.00
1,665.00
Reconciled Depreciation
1,648.00
1,505.00
1,119.00
359.00
65.00
Net Income from Continuing Operation Net Minority Interest
-4,218.00
-8,278.00
-19,528.00
-6,826.00
-11,687.00
Total Unusual Items Excluding Goodwill
--
--
--
2,256.00
-4,704.00
Total Unusual Items
--
--
--
2,256.00
-4,704.00
Normalized EBITDA
-2,001.00
-6,613.00
-17,546.00
-6,433.00
-6,617.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
--
12/31/2020 - 5/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOV.TA Bio-View Ltd
30.20
+4.50%
EPIT.TA Epitomee Medical Ltd
950.00
-0.26%
IOB.DU Ion Beam Applications SA
12.98
-2.41%
EMTC-M.TA Elbit Medical Technologies Ltd
18.30
+4.57%
ALMD.TA Allmed Solutions Ltd
31.50
-1.56%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
2SE.F Sequana Medical NV
2.5400
-1.17%
NEOLA.ST Neola Medical AB (publ)
2.5400
-0.78%
8C4.F CYBERDYNE Inc.
1.0440
-0.19%
HUMX.TA Human Xtensions Ltd.
31.40
0.00%